Assessment of tumour KRAS status in lung adenocarcinoma patients using the Sequenom's MassARRAY technology. Why and how?M. Ilie,N. Guibert,V. Hofman,N. Ebran,P. Brest,O. Bordonne,K. Ilc,M. Poudenx,C. H. Marquette,G. Milano,P. HofmanVIRCHOWS ARCHIV（2014）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
